These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 38900236

  • 1. Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K/Akt/mTOR pathway.
    Ganesan K, Xu C, Wu J, Du B, Liu Q, Sui Y, Song C, Zhang J, Tang H, Chen J.
    Sci China Life Sci; 2024 Sep; 67(9):1849-1866. PubMed ID: 38900236
    [Abstract] [Full Text] [Related]

  • 2. Ginsenoside 20(S)-protopanaxadiol inhibits triple-negative breast cancer metastasis in vivo by targeting EGFR-mediated MAPK pathway.
    Peng B, He R, Xu Q, Yang Y, Hu Q, Hou H, Liu X, Li J.
    Pharmacol Res; 2019 Apr; 142():1-13. PubMed ID: 30735802
    [Abstract] [Full Text] [Related]

  • 3. Rhizoma Amorphophalli inhibits TNBC cell proliferation, migration, invasion and metastasis through the PI3K/Akt/mTOR pathway.
    Wu C, Qiu S, Liu P, Ge Y, Gao X.
    J Ethnopharmacol; 2018 Jan 30; 211():89-100. PubMed ID: 28962890
    [Abstract] [Full Text] [Related]

  • 4. Sophoraflavanone G suppresses the progression of triple-negative breast cancer via the inactivation of EGFR-PI3K-AKT signaling.
    Cheng W, Liu D, Guo M, Li H, Wang Q.
    Drug Dev Res; 2022 Aug 30; 83(5):1138-1151. PubMed ID: 35426453
    [Abstract] [Full Text] [Related]

  • 5. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
    Li Y, Hu S, Chen Y, Zhang X, Gao H, Tian J, Chen J.
    Phytomedicine; 2023 Sep 30; 118():154924. PubMed ID: 37393829
    [Abstract] [Full Text] [Related]

  • 6. Luteolin suppresses androgen receptor-positive triple-negative breast cancer cell proliferation and metastasis by epigenetic regulation of MMP9 expression via the AKT/mTOR signaling pathway.
    Wu HT, Lin J, Liu YE, Chen HF, Hsu KW, Lin SH, Peng KY, Lin KJ, Hsieh CC, Chen DR.
    Phytomedicine; 2021 Jan 30; 81():153437. PubMed ID: 33352494
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Combination of monensin and erlotinib synergistically inhibited the growth and cancer stem cell properties of triple-negative breast cancer by simultaneously inhibiting EGFR and PI3K signaling pathways.
    Fang T, Hu S, Song X, Wang J, Zuo R, Yun S, Jiang S, Guo D.
    Breast Cancer Res Treat; 2024 Sep 30; 207(2):435-451. PubMed ID: 38958784
    [Abstract] [Full Text] [Related]

  • 11. Vitexin Inhibits TNBC Progression and Metastasis by Modulating Macrophage Polarization Through EGFR Signaling.
    Lin Y, Li L, Huang H, Wen X, Zhang Y, Zhang R, Huang W.
    J Immunother; 2024 Oct 01; 47(8):303-312. PubMed ID: 38847148
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antrodia camphorata inhibits epithelial-to-mesenchymal transition by targeting multiple pathways in triple-negative breast cancers.
    Hseu YC, Chang GR, Pan JY, Rajendran P, Mathew DC, Li ML, Liao JW, Chen WT, Yang HL.
    J Cell Physiol; 2019 Apr 01; 234(4):4125-4139. PubMed ID: 30146779
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Silence of α1-Antitrypsin Inhibits Migration and Proliferation of Triple Negative Breast Cancer Cells.
    Zhao Z, Ma J, Mao Y, Dong L, Li S, Zhang Y.
    Med Sci Monit; 2018 Sep 27; 24():6851-6860. PubMed ID: 30260937
    [Abstract] [Full Text] [Related]

  • 16. Antitumor Effects of Ononin by Modulation of Apoptosis in Non-Small-Cell Lung Cancer through Inhibiting PI3K/Akt/mTOR Pathway.
    Gong G, Ganesan K, Xiong Q, Zheng Y.
    Oxid Med Cell Longev; 2022 Sep 27; 2022():5122448. PubMed ID: 36605098
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. PARP1 promotes EGFR-TKI drug-resistance via PI3K/AKT pathway in non-small-cell lung cancer.
    Xu X, Liu Y, Gong Q, Ma L, Wei W, Zhao L, Luo Z.
    Cancer Chemother Pharmacol; 2024 Aug 27; 94(2):209-221. PubMed ID: 38609654
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway.
    Han J, Yu J, Dai Y, Li J, Guo M, Song J, Zhou X.
    Bosn J Basic Med Sci; 2019 Feb 12; 19(1):52-59. PubMed ID: 29924958
    [Abstract] [Full Text] [Related]

  • 20. Rotenone restrains colon cancer cell viability, motility and epithelial‑mesenchymal transition and tumorigenesis in nude mice via the PI3K/AKT pathway.
    Xiao W, Liu Y, Dai M, Li Y, Peng R, Yu S, Liu H.
    Int J Mol Med; 2020 Aug 12; 46(2):700-708. PubMed ID: 32626924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.